NMAP protein in new kidney or liver tumors
Treatments studied
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at a protein called NMAP in people who have a new kidney or liver mass that will be surgically removed. It helps researchers understand how this protein relates to cancer and might lead to better tests or treatments in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You have a newly found mass (growth) in your kidney or liver that doctors plan to remove with surgery.
- You have not had any previous treatment (like medication or therapy) for this mass.
- You are healthy enough to undergo surgery (your heart, lungs, and other organs work well).
- You have not had any other cancer in the last 5 years.
- You have not had a major surgery (using general anesthesia) in the past month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a simple blood test can help doctors tell if a kidney mass is cancer before surgery. It aims to improve how kidney masses are classified and guide treatment decisions.
This study follows people with newly diagnosed kidney cancer who have not started treatment. It tests whether a special blood test can monitor the cancer over time, alongside standard follow-up after planned surgery.
This trial tests a new PET/CT scan that uses a special tracer to find clear cell kidney cancer. If you are scheduled for kidney tumor removal, this scan may help your surgeon see the cancer more clearly before surgery.
This trial tests a special PET scan to see if it can better find leftover kidney cancer after surgery compared to a standard CT scan. You may qualify if you had kidney cancer surgery within the last 4-16 weeks and are at high risk of the cancer coming back.
This trial tests a new imaging agent (68Ga-NYM096) that may help doctors see whether a kidney mass is cancer before surgery. By undergoing a PET/CT scan with this agent, you might help doctors better plan your surgery and avoid unnecessary procedures.
This study looks at whether a simple blood test can detect tiny bits of kidney cancer DNA after surgery. If successful, it could help doctors spot a return of cancer earlier than scans alone.
Hear when a new Carcinoma, Renal Cell trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.